drugset / Trial / NCT00785512
A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nebivolol | Other / unclassified | 10 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 20 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 40 mg | Oral |